Bristol-Myers Squibb is combining its protease inhibitor Reyataz (atazanavir sulfate) with a pharmacoenhancing agent from Gilead Sciences Inc. called... Read More
Moderna recently registered a significant triumph in its ongoing patent dispute concerning its Covid-19 vaccine against Pfizer and BioNTech. The... Read More